Park Square is pleased to announce the appointment of Qin Yu, Ph.D., to the position of Vice President, Discovery at Carmine Therapeutics. Carmine Therapeutics is a venture backed therapeutics company whose vision is to make genetic medicines broadly accessible to address the unmet medical needs of patients.
Yu most recently served as Senior Director, Viral Therapeutics at Limelight Bio. Previously, Yu served in various roles at Rubius Therapeutics, including Director, Platform Technology. Earlier in her career, Yu served as Principal Scientist, Team Leader/Project Leader at AstraZeneca.
Yu received her B.S. in Cell Biology and her M.S. in Cell Biology from Peking University and her Ph.D. in Microbiology from University of Alabama.
Park Square Executive Search serves companies and institutions that are shaping the world through discovery, innovation and growth. Our clients are leading life sciences and healthcare organizations, technology companies, major research universities, and venture capital and private equity firms, including their portfolio companies. We place board members, chief executive officers, C-suite executives, and academic leaders.